NEWPORT BEACH, Calif., April 26 /PRNewswire/ -- Versant Ventures, a leading healthcare venture capital firm, announced that Charles Warden has been appointed as a Managing Director effective July 1, 2004. Mr. Warden will be working out of Versant's Newport Beach office focusing on the medical device sector. Mr. Warden joins Versant from Schroder Ventures Life Sciences, a well-respected health care-focused venture capital fund, where he served as a General Partner working out of their Boston office.
"We are truly excited to welcome Charles to the Versant team," commented William J. Link, Ph.D., Managing Director, Versant Ventures. "His proven track record in the medical device sector is an excellent complement to our existing team. His addition reinforces our continued commitment to medical device investing and further strengthens our presence in the Southern California venture capital community."
Mr. Warden brings more than ten years of expertise to medical device- focused investment. He joined Schroder Ventures in 1996, where he focused on medical device transactions. Previously, Mr. Warden worked with Boston Capital Ventures where he concentrated on medical device and other healthcare investments. Earlier, he was a consultant with Monitor Company, a strategy consulting firm. Mr. Warden currently serves on various medical device company boards including Acufocus, CardioFocus, Confluent Surgical, Concentric Medical, Insulet, Liposonix, MicroMed Technology, Sadra Medical and Neovista. He is also involved with The Innovation Factory, a medical devices incubator. Mr. Warden graduated with an M.B.A. degree from Harvard Business School and holds a B.A. degree from Beloit College.
About Versant Ventures
Founded in 1999, Versant Ventures currently manage $680 million in committed capital. Since its formation, Versant has invested in more than 50 companies in the Medical Device, Biotech, Healthcare Services and Healthcare Information Technology sectors. The Versant team of twelve investment professionals located in Menlo Park and Newport Beach bring together more than 175 years of combined experience and success as venture capitalists and entrepreneurs. Versant invests in early-stage healthcare companies promising to be significant, long-term market leaders. Versant funds and nurtures companies with experienced entrepreneurs, a proprietary product or service with a sustainable competitive advantage, large market potential and a realistic business model. For additional information, please visit http://www.versantventures.com/.
CONTACT: William J. Link, Ph.D., Managing Director of Versant Ventures,949-729-4500; or Karen L. Bergman or Michelle Corral, 650-575-1509 or415-794-8662, both of BCC Partners for Versant Ventures